C. Aznar et al., PREVALENCE OF ANTI-R-13 ANTIBODIES IN HUMAN TRYPANOSOMA-CRUZI INFECTION, FEMS immunology and medical microbiology, 12(3-4), 1995, pp. 231-237
Infection with Trypanosoma cruzi develops in three phases: acute, inde
terminate or asymptomatic, and chronic phase (with cardiac or digestiv
e manifestations). Moreover, transmission may occur from infected moth
ers to newborn, the so-called congenital form. In the present study, h
umoral responses against T. cruzi total extract and against the 13 ami
no acid peptide named R-13 derived from the parasite ribosomal P prote
in, previously described as a possible marker of chronic Chagas heart
disease, were determined in chagasic patients and in blood bank donors
from endemic areas. While in sera from acute phase, only IgM anti-T.
cruzi response was observed, both IgM and IgG anti-T. cruzi antibodies
were detected in sera from congenitally infected newborns. The percen
tage of positive response in sera from blood bank donors was relativel
y high in endemic regions, Antibodies against the R-13 peptide were pr
esent in a large proportion of cardiac chagasic patients but were tota
lly lacking in patients with digestive form of Chagas' disease. Furthe
rmore, anti-R-13 positive responses were detected in congenitally infe
cted newborns.